Navigation Links
GBS/CIDP Foundation to Hold 10th International Symposium
Date:10/7/2008

Over 250 medical professionals, patients and caregivers from around the

world expected to attend

NARBERTH, Pa., Oct. 7 /PRNewswire/ -- The GBS/CIDP Foundation International will host its tenth international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Bloomingdale, IL on November 7-9, 2008. Over 250 medical professionals, current and former patients and caregivers from all over the world are expected to attend the three-day event at the Indian Lake Resort.

In addition to general sessions covering the latest developments in current research, diagnosis, treatment and therapies for GBS & CIDP, there will be over twenty workshops offering practical information for patients, caregivers and their physicians. Topics include patient management and long-term outcomes for GBS, CIDP and variants, fatigue, pain and emotional issues, reimbursement and disability, and special sessions for rehabilitation and wheelchair patients.

Speakers and presenters include prominent neurologists who actively treat GBS and CIDP patients and conduct vital research, leading physicians in rehabilitation medicine and physicians who themselves have had the disorder. The symposium will provide invaluable information and networking opportunities for patients, relatives and caregivers who have experienced or had to deal with these rare and potentially catastrophic disorders.

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms. It is caused by damage to the covering of the nerves, called myelin.

The Foundation was founded in 1980 by Robert and Estelle Benson to assist GBS patients and their families. A non-profit volunteer organization, it is dedicated to supporting patients and families through its national office and 160 chapters with more than 26,000 members around the globe. In addition to education of the public and medical communities the Foundation is dedicated to funding medical research and supporting patient advocacy.

For information about the Foundation or the Symposium, call toll free 866-224-3301 or visit http://www.gbs-cidp.org, or e-mail info@gbs-cidp.org.

For further information, contact:

Estelle Benson

Executive Director

(610) 667-0131

(866) 224-3301 (toll free)


'/>"/>
SOURCE The GBS/CIDP Foundation International
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
7. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
8. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
9. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... December 8, 2016 ... Molekulargenetik, erweitert seine Palette an anpassbaren SureSeq™ NGS-Panels ... FH Panels, das ein schnelles und kostengünstiges Studium ... Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide ... einem einzigen kleinen Panel und ermöglicht eine individuelle ...
(Date:12/8/2016)... -- Anaconda BioMed S.L., a pre-clinical stage medical device company ... system for the treatment of Acute Ischemic Stroke (AIS), ... join its Scientific Advisory Board (SAB). The SAB is ... and clinical experts to Anaconda BioMed S.L., as the ... to its clinical phase. The SAB is also ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... ... 08, 2016 , ... This CAST literature review and report looks at problems ... on the economic effects in countries that are major global commodity exporters and importers, ... resultant risk of low level presence (LLP) puts large volumes of trade worth billions ...
Breaking Biology Technology:
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the ... Counting technology, entered into a license and supply agreement ... science. The agreement provides Singulex access to Thermo Scientific ... Europe is used to diagnose systemic bacterial ... States to aid in assessing the risk ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):